Page last updated: 2024-09-04

technetium tc 99m diphosphonate and Mandibular Diseases

technetium tc 99m diphosphonate has been researched along with Mandibular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo, Y; Funayama, H; Kawamura, H; Oizumi, T; Sugawara, S; Yamaguchi, K1

Other Studies

1 other study(ies) available for technetium tc 99m diphosphonate and Mandibular Diseases

ArticleYear
Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2010, Volume: 68, Issue:4

    Topics: Aged; Aged, 80 and over; Binding, Competitive; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Inflammation Mediators; Lipopolysaccharides; Mandibular Diseases; Nitrogen; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Radionuclide Imaging; Radiopharmaceuticals; Risedronic Acid; Technetium Compounds; Tooth Extraction

2010